首页> 外文期刊>PLoS One >Molecular Characterisation of Trimethoprim Resistance in Escherichia coli and Klebsiella pneumoniae during a Two Year Intervention on Trimethoprim Use
【24h】

Molecular Characterisation of Trimethoprim Resistance in Escherichia coli and Klebsiella pneumoniae during a Two Year Intervention on Trimethoprim Use

机译:甲氧苄啶使用两年的干预期间大肠埃希菌和肺炎克雷伯菌中甲氧苄啶抗性的分子表征

获取原文
           

摘要

Background Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an intervention on trimethoprim use was conducted in Kronoberg County, Sweden, resulting in 85% reduction in trimethoprim prescriptions. We investigated the distribution of dihydrofolate reductase (dfr)-genes and integrons in Escherichia coli and Klebsiella pneumoniae and the effect of the intervention on this distribution. Methodology/Principal Findings Consecutively isolated E. coli (n = 320) and K. pneumoniae (n = 54) isolates phenotypicaly resistant to trimethoprim were studied. All were investigated for the presence of dfrA1, dfrA5, dfrA7, dfrA8, dfrA12, dfrA14, dfrA17 and integrons class I and II. Isolates negative for the seven dfr-genes (n = 12) were also screened for dfr2d, dfrA3, dfrA9, dfrA10, dfrA24 and dfrA26. These genes accounted for 96% of trimethoprim resistance in E. coli and 69% in K. pneumoniae. The most prevalent was dfrA1 in both species. This was followed by dfrA17 in E. coli which was only found in one K. pneumoniae isolate. Class I and II Integrons were more common in E. coli (85%) than in K. pneumoniae (57%). The distribution of dfr-genes did not change during the course of the 2-year intervention. Conclusions/Significance The differences observed between the studied species in terms of dfr-gene and integron prevalence indicated a low rate of dfr-gene transfer between these two species and highlighted the possible role of narrow host range plasmids in the spread of trimethoprim resistance. The stability of dfr-genes, despite large changes in the selective pressure, indirectly suggests a low fitness cost of dfr-gene carriage.
机译:背景肠杆菌科中甲氧苄啶的耐药性正在增加。在2004-2006年,在瑞典克罗诺贝格县进行了甲氧苄氨嘧啶使用的干预,导致甲氧苄氨嘧啶处方减少了85%。我们调查了大肠埃希菌和肺炎克雷伯菌中二氢叶酸还原酶(dfr)基因和整合子的分布以及干预对这种分布的影响。方法/主要发现研究了连续分离的对甲氧苄啶具有表型代表性的大肠杆菌(n = 320)和肺炎克雷伯氏菌(n = 54)。研究了所有的dfrA1,dfrA5,dfrA7,dfrA8,dfrA12,dfrA14,dfrA17和整数I和II类整数的存在。还针对dfr2d,dfrA3,dfrA9,dfrA10,dfrA24和dfrA26对7个dfr基因的阴性分离株(n = 12)进行了筛选。这些基因在大肠杆菌中占甲氧苄啶抗药性的96%,在肺炎克雷伯菌中占69%。在这两个物种中,最普遍的是dfrA1。其次是在大肠杆菌中的dfrA17,仅在一种肺炎克雷伯菌中被发现。一类和二类整合素在大肠埃希菌(85%)中比肺炎克雷伯菌(57%)更常见。在2年的干预过程中,dfr基因的分布没有改变。结论/意义在所研究物种之间就dfr基因和整合子普遍性所观察到的差异表明,这两个物种之间dfr基因转移的速率较低,并突出了窄宿主范围质粒在甲氧苄啶抗性传播中的可能作用。尽管选择性压力发生了很大变化,但dfr基因的稳定性间接表明dfr基因携带的适应性成本较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号